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Acapsular Staphylococcus aureus 
with a non‑functional agr regains 
capsule expression after passage 
through the bloodstream 
in a bacteremia mouse model
carlos M. Suligoy1, Rocío e. Díaz1, Ana‑Katharina Gehrke2, natalie Ring3, Gonzalo Yebra3, 
Joana Alves3, Marisa i. Gómez2, Sindy Wendler4, J. Ross fitZGeRALD3, Lorena tuchscherr4, 
Bettina Löffler4, Daniel o. Sordelli1*, Mariángeles noto Llana1 & fernanda R. Buzzola1
Selection pressures exerted on Staphylococcus aureus by host factors during infection may lead to 
the emergence of regulatory phenotypes better adapted to the infection site. traits convenient for 
persistence may be fixed by mutation thus turning these mutants into microevolution endpoints. The 
feasibility that stable, non‑encapsulated S. aureus mutants can regain expression of key virulence 
factors for survival in the bloodstream was investigated. S. aureus agr mutant HU-14 (IS256 insertion 
in agrC) from a patient with chronic osteomyelitis was passed through the bloodstream using a 






noncoding region between dnaG (DNA primase) and rpoD (sigA). this loss may be associated with the 
observed phenotype change but the mechanism remains unknown. in conclusion, S. aureus organisms 
that escape the infected bone may recover the expression of key virulence factors through a rapid 
microevolution pathway involving SigB regulation of key virulence factors.
Staphylococcus aureus is a transient, sometimes permanent member of the human microbiota in the nares and 
skin of a significant number of healthy individuals. As predisposing conditions emerge in the host, this oppor-
tunistic species may cause infections with different severity, ranging from mild skin and soft tissue infection to 
severe disseminated  disease1,2. Treatment of S. aureus infections is hampered by widespread dissemination of 
methicillin-resistant S. aureus (MRSA)3 and by the frequent emergence of S. aureus with low level resistance to 
 vancomycin4. Whereas MRSA was primarily considered a nosocomial  pathogen5, it is now unanimously accepted 
that MRSA also affects individuals of the general community with no previous exposure to health care  settings6,7. 
Up to 1.5–2% of patients receiving an orthopedic prosthetic device becomes infected and a significant number 
of these infections are caused by S. aureus. Most osteomyelitis caused by S. aureus become refractory to antibi-
otic treatment soon after bacteria settles on the prosthetic device surface and in bone  tissue1. S. aureus has the 
ability to swiftly adapt to the conditions encountered at the infection niche by adjusting its metabolism and/or 
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regulating the expression of virulence factors required for successful establishment at the incipiently colonized 
tissue. Once S. aureus has adapted to the microenvironment certain traits may be fixed by mutations, which occur 
as osteomyelitis becomes  chronic8,9. Indeed, selection pressure exerted by a vast number of yet undefined host 
factors would permit the emergence of bacterial variants more suitable to evade immune defense mechanisms 
and cause infection refractory to antibiotic treatment in the absence of genes that code antibiotic resistance.
Staphylococcus aureus possesses a vast repertoire of virulence and immune evasion factors that facilitates its 
dual life-style as either a commensal or a  pathogen1,10. More important, S. aureus displays a complex regulatory 
network, composed of a number (as yet not fully known) of genes which allow the crosstalk between  regulators11 
thus permitting this species to rapidly switch on and off virulence factors to adapt to and survive in changing 
microenvironments. One of the strategies to investigate which factors may be up- or down-regulated during 
adaptation is to assess whether any of these factors is fixed by mutation during chronic infection. Among these 
factors, loss of short sequence–repeats in the protein A Xr region, small colony variant (SCV) emergence and loss 
of capsular polysaccharide (CP) expression can be  mentioned12–15. Furthermore, we were able to demonstrate 
that the loss of CP expression due to a mutation in the agr occurs during chronic  osteomyelitis9. This finding 
suggested that loss of RNAIII expression may yet be another endpoint in microevolution since agr regulates the 
expression of a vast number of virulence factors.
CP5 and CP8 are produced by a 75 to 80% of S. aureus isolates from humans and play a significant role in the 
pathogenesis of staphylococcal  infections16. Isolates of S. aureus that fail to produce CP5 or CP8 and that produce 
non-mucoid colonies on solid media are defined as non-typeable (NT) regardless the mechanism responsible 
for the lack of CP  expression17. CP5 and CP8 are virulence factors that permit S. aureus to avoid phagocytosis 
and facilitate bloodstream  dissemination18,19. Once established in the bone of the patient with chronic osteomy-
elitis it appears advantageous for S. aureus to loose CP  expression15 to remain undisturbed within the infected 
bone. To support the hypothesis that loss of CP expression may initially be due to regulation, in a very recent 
study it was demonstrated that S. aureus can express CP in vivo, even though production in vitro cannot be 
 demonstrated20. These findings showed that S. aureus can switch on or off CP expression according to the in vivo 
microenvironment surrounding bacteria. In the present study, we investigated whether S. aureus can regain the 
ability to produce CP, even in the presence of a mutated non-functional Agr, when it is transferred from infected 
bone to the bloodstream.
Results
Mouse passages of strain HU-14.  Strain HU-14 lacks CP5 expression due to an IS256 insertion in agrC. 
Strain HU-14 was passed through blood using the bacteremia mouse model and the emergence of colonies with 
positive reaction to anti-CP5 immune serum was monitored by colony immunoblot assay. After passage #3 
(Fig. 1a) a colony (#1) reacting to anti-CP5 was pinpointed (Figs. 1b and 1c), which was recorded as strain P3.1. 
Other suspicious colonies from the same passage were tested for CP expression but only P3.1 was confirmed as 
CP5 positive (Fig. 1d). The P3.1 colony was amplified and subcultured several times to assess phenotype stability 
and after 7 passages on TSA the CP5 phenotype remained stable.
Isolate P3.1 characterization.  Phenotypic characterization revealed that strains HU-14 and P3.1 have 
almost identical mean generation times (MGT) (40  min and 39  min, respectively). Biofilm production was 
significantly higher (p < 0.0001, Student t test) in the P3.1 derivative  [ODB/ODG = 0.60 ± 0.02 (n = 42)] when 
compared with the parental HU-14 strain  [ODB/ODG = 0.35 ± 0.01 (n = 42)], as assessed by the crystal violet 
test. Total hemolytic activity was negative for both strains as well as for alpha- and beta-hemolysins. Proteolytic 
activity was negative for both strains too. Both strains were vancomycin susceptible. Transcriptional evaluation 
of the Agr system in HU-14 and P3.1 revealed that the expression of RNAIII and agrA was still abolished in 
P3.1 as ascertained through qRT-PCR (Fig. 2a). Amplification of the P3.1 agrC gene produced an amplicon of 
identical size (2,793 bp) to that observed in HU-14, which suggested that IS256 remained positioned in the agrC 
gene of isolate P3.1 (Fig. 2b). Sequence analysis revealed that the insertion site of IS256 in agrC was identical 
in both strains and positioned after base 218. In synthesis, S. aureus regained CP expression in the absence of 
a functional Agr system (lack of RNAIII and agrA expression). Another noticeable phenotypic feature was that 
P3.1 produced the classical yellowish-golden colonies that give the name to this bacterial species whereas its 
parental HU-14 strain produced whitish colonies on TSA (Fig. 3a). Methanolic extracts from HU-14 exhibited 
a significantly lower absorbance at 450 nm when compared with those of P3.1, which suggested that P3.1 pro-
duced increased levels of staphyloxanthin (Fig. 3b). 
Whole genome sequence analysis. Analysis using Illumina short read sequences confirmed that HU-14 
and P3.1 were isogenic, with only one single nucleotide polymorphism (SNP) in P3.1. It consisted of replace-
ment of C by T in position 589 of the icaA gene, leading to a change from alanine to threonine in position 197. 
Phenotypical analysis of the icaADBC product, namely the polysaccharide intercellular adhesin (PIA) revealed 
negligible PIA production with no significant differences between HU-14 and P3.1 (Fig. 4). In addition to agrC, 
which was mutated by the IS256 insertion in both strains, further short read sequence analysis determined that 
no genomic modification of any other known major regulator occurred which may explain the P3.1 capsulated 
phenotype. Furthermore, no SNP was found in the intergenic regions which may affect the expression of any 
regulator.
Pacific Biosciences sequencing was performed to assess whether there was any structural difference between 
the HU-14 and P3.1 genomes. Hybrid Unicycler assembly of PacBio and Illumina reads resulted in two genome 
fragments. The smaller fragment in the HU-14 and P3.1 hybrid Unicycler assemblies was a circular sequence that 
shared 99.98% and 99.80% identity respectively with plasmid pCM05 (PLSDB database). Annotation with Prokka 
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using the pCM05 plasmid from the NCBI GenBank Database (NC_013332.1) as a reference and SnapGene side-
by-side analysis with the pCM05 GenBank file confirmed that the circular sequence was indeed pCM05 in both 
assemblies, and contained all the same genes and restriction sites. The plasmid sequences were also aligned using 
ProgressiveMaude, but these did not show any rearrangements.
The size of the larger fragment (2,972,382 bp and 2,971,047 bp in HU-14 and P3.1, respectively) was con-
sistent with that of the S. aureus chromosome. Whole genome alignment of the chromosome sequences was 
performed using progressiveMauve, showing no chromosomal rearrangements between the two. However, 
annotation with Prokka revealed that P3.1 has lost one IS256 copy originally located in the non-coding region 
downstream of DNA primase (dnaG, LJDFIFNA_00432) and upstream of RNA polymerase sigma factor RpoD 
Figure 1.  (a) Mouse experiment flowchart. Mice were injected by the i.p. route with 1 × 108 CFU of S. aureus 
HU-14. After 24 h mice were sacrificed and blood obtained by cardiac puncture. Blood was plated quantitatively 
and after an overnight culture all colonies from a plate were harvested and suspended in PBS, and the 
suspension adjusted to a density of 1 × 109 per ml for further injection to another group of mice. Suspension 
aliquots were plated for CFU count and colony immunoblots were performed on the grown TSB plates to detect 
the emergence of any colony producing CP5. (b) Colony immunoblot of strain HU-14 after three passages 
through mice. The arrows indicate strains Reynolds CP5, Reynolds CP8 and Reynolds NT. These three control 
strains were added by impregnation of the blot membrane. (c) Magnification of the photograph shown in (b). 
The arrow indicate colony #1, later identified as P3.1. (d) P3.1 was confirmed as CP5. Positive control was strain 
Reynolds CP5 (lower left strike). Negative control was Reynolds NT (lower right strike).
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(rpoD, LJDFIFNA_00434) (sigA) (Suppl Fig. 1). IS256 excision in P3.1 was clean and left a conserved region 
between dnaG and rpoD identical to those of N315, USA300 and other ST5 isolates from our collection.
Interestingly, when both hybrid assembly and only short read analysis was performed the IS256 was defini-
tively missing in P3.1 but such excision was not pinpointed by performing long read analysis only. Finally, SNP-
calling between the two closed hybrid genomes was carried out using Snippy, with the Prokka-annotated HU-14 
closed reference genome and the P3.1 Illumina reads, and vice-versa. This revealed the same single SNP as the 
same analysis using just the Illumina reads: an inconsequential change from alanine in HU-14 to threonine in 
P3.1, as described above.
Regulation of CP5 expression.  It is known that regulation of CP5(8) expression in S. aureus is complex 
and involves a number of redundant mechanisms that act in concert. Evaluation of main S. aureus regulators sae 
and sarA at the transcriptional level by qRT-PCR revealed that no functional modification occurred (data not 
shown). However, transcription of asp23, a gene that is solely regulated by SigB, was significantly increased in 
P3.1 when compared with HU-14 (Fig. 5). Since staphyloxanthin production by S. aureus is positively regulated 
by SigB, the increased pigmentation displayed by P3.1 supports the hypothesis that S. aureus P3.1 reacquired 
the capacity to produce CP5 through a mechanism related to recovery of SigB functionality, in the absence of an 
operative Agr system.
Virulence study. The virulence of strain HU-14 and derivative P3.1 was tested in a mouse model of intra-
peritoneal injection. Mortality 5 days after challenge with P3.1 was higher than that in the group challenged with 
HU-14 but was not significantly different (Suppl Fig. 2a). Body weight was recorded over 5 days after challenge 
and the results showed that mice challenged with the P3.1 derivative lost more weight than those injected with 
the parental strain HU-14, but the differences were again not significant (Suppl Fig.  2b). Interestingly, mice 
challenged with P3.1 exhibited more prominent signs of distress, such as hunched posture and spiky fur, when 
compared with those challenged with HU-14.
Figure 2.  (a) Quantitative real time PCR of RNAIII and agrA transcripts from strains HU-14 and derivative 
P3.1. S. aureus strain 6,850 was used as reference. Changes in gene expression are shown as normalized 
mean fold change  2-ΔCt. Data were normalized to 16S expression. The data represent the mean of duplicate 
measurements from 3 independent experiments. (b) Electrophoretic run of agrC PCR amplicons. HU-14 and 
P3.1 rendered amplicons of identical size, larger than that obtained from control strain HU-8 with a conserved 
agrC. Lane (-) contains no DNA. The original gel image is shown in Suppl. Figure 3. The result obtained shows 
that the IS256 insertion remains in place within agrC in derivative P.3.1.
5
Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:14108  | https://doi.org/10.1038/s41598-020-70671-1
www.nature.com/scientificreports/
Figure 3.  (a) Strain HU-14 and P3.1 colonies on TSA showing the different pigmentation level. Panel b: 
pigments were extracted S. aureus strains with methanol and the optical density ratios at 450 nm/600 nm were 
measured. Sample size in each column varied from 4 to 18. The P3.1 methanolic extract produced a significantly 
higher absorbance when compared with the parental HU-14 strain. (*) p = 0.0121, Student t test for unpaired 
samples. S. aureus RN6911 does not produce staphyloxanthin and SH1000 is a heavy staphyloxanthin producer 
strain.
Figure 4.  PIA in biofilms produced by S. aureus HU-14 and P3.1. Strains SA113 and MBD034 were included as 
positive standard and negative control, respectively. Each bar represents the arithmetic mean ± SEM from 4 to 6 
wells from 3 separate experiments. PIA production values are the OD at 595 nm of crystal violet  (ODB) relative 
to the final culture density  (ODG) after 24 h incubation. There was no significant difference between HU-14 and 
P3.1 (ordinary one-way ANOVA, Tukey´s test, Brown-Forsythe post-test).
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osteoclastogenesis and cytokine production studies. The differential capacity of strains HU-14 and 
P3.1 to trigger osteoclastogenesis was investigated in vitro. Osteoclast precursors were stimulated with S. aureus 
in the presence of M-CSF. Forty-eight hours after stimulation cells were fixed and multinucleated TRAP ( +) cells 
were counted. Rapid differentiation into osteoclasts was induced by HU-14 with formation of multinucleated 
cells (3 or more nuclei) (Fig. 6a,b). In contrast, significantly decreased numbers of osteoclasts were observed 
when the osteoclast precursors were stimulated with P3.1 (Fig. 6a,b). S. aureus HU-14 and its P3.1 derivative 
were tested for their capacity to induce the production of TNF-α, a proinflammatory cytokine involved in osteo-
clastogenesis, by osteoclast precursors in culture. The P3.1 derivative exhibited a decreased capacity to trigger 
TNFα secretion (Fig. 6c).
Discussion
Staphylococcus aureus has the potential to adapt to diverse niches with defined  microenvironments21. In a recent 
study we showed that a stable non-encapsulated derivative emerged during chronic osteomyelitis and displaced a 
more virulent CP8 parental strain which had been isolated several months before from the same infection  site9 . 
The S. aureus derivative, which bore a frameshift mutation in agrC that caused loss of both RNAIII transcription 
and CP8 expression, was considered a microevolution endpoint adapted to bone. Lack of CP expression benefits 
the interaction between surface S. aureus adhesins and eukaryotic cell receptors thus promoting internalization 
of bacteria into the eukaryotic cell  milieu8. Intracellular location, reduced capacity to cause  inflammation13,22, 
increased biofilm production and SCV  formation23 may explain why not only S. aureus pulmonary infection 
of cystic fibrosis  patients24 but also S. aureus osteomyelitis become refractory to antibiotic treatment in spite 
of appropriate antibiotic treatment. From our bacterial collection we selected non-encapsulated S. aureus iso-
late HU-14 with a non-functional agr due to an IS256 insertion in agrC. Although HU-14 may be considered 
a microevolution endpoint, in the present study we show that the passage of this isolate through blood in an 
experimental mouse model induced the reversion from a NT to a CP5 phenotype. Interestingly, it was not a true 
genetic reversion since IS256 remained inserted at the same location in the agrC of the CP5 isogenic derivative. 
Therefore, loss of the agr functionality due to a stable mutation (in this case caused by an IS256 insertion) may 
only be considered a microevolution endpoint at the precise niche where selection initially took place.
A variable number of relevant S. aureus isolates are non-reactive to antibodies anti-CP5 and anti-CP8 as 
phenotypically ascertained in vitro in the clinical bacteriology laboratory. Diverse mechanisms responsible for 
the loss CP5(8) expression have been reported, one of which is related to dysfunction of the main global regu-
lator  Agr17. There is ample evidence that agr-deficient strains may not only be selected during  infection25 but 
also colonize healthy  hosts26. In a study on 195 S. aureus isolates collected from different sources it was found 
that 49% of the isolates carried an inactive agr locus, as shown by the lack of a RNAIII  transcript27. In the same 
study, interestingly, 55% of the strains with a non-functional agr produced capsule (CP5 or CP8). Such find-
ing permits to speculate that the type of S. aureus derivative obtained after passage through the bloodstream 
described in the present report, which produce CP5 in the absence of a functional agr, may not be a rare event in 
clinical practice after all. CP5(8) is a strong candidate for construction of a multicomponent vaccine to prevent 
S. aureus severe  infections28. Indeed, the most promising preparations contain CP conjugated to a toxoid plus 
other relevant  antigens16,29–31. The finding that prevalent clone USA300 in the USA is non-encapsulated due to 
mutations in the capsular genes rather than in a capsule  regulator32 appeared to cast doubt on the inclusion of 
CP as vaccine component. But on the other hand, many S. aureus clinical isolates carry a conserved cap cluster 
and, furthermore, it was recently demonstrated that clinical strains that do not produce CP in vitro are able 
Figure 5.  Quantitative real time PCR of asp23 and sigB transcripts from strains HU-14 and derivative P3.1. 
S. aureus strain 6850 was used as reference. Changes in gene expression are shown as normalized mean fold 
change  2-ΔCt. Data were normalized to 16S expression. The data represent the median of duplicate measurements 
from 3 independent experiments. (*) Significant difference with p = 0.0070 (Mann–Whitney test).
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to produce CP in vivo20. Our present study demonstrates the feasibility that S. aureus may recover in a stable 
manner CP5 production, which facilitates phagocytosis evasion once bacteria reach the bloodstream, in spite 
of a non-functional Agr. The results of our study suggest that the inclusion of CP in a multicomponent vaccine 
preparation should not be dismissed.
Staphylococcus aureus possesses an intricate regulatory system that governs the production of soluble viru-
lence factors and exoenzymes. In addition to Agr, main regulators include a number of two-component systems, 
such as SaeRS, transcriptional  factors33, such as SarA and its  homologues34 and factor σB (sigB)35. Bioinformatic 
analysis of strains HU-14 and P3.1 sequences revealed that the sequences of the aforementioned regulators were 
conserved, with no differences between the parental strain and the derivative. Since it was recently demonstrated 
that CP production is up regulated by SigB we focused our attention on this  regulator36. The SigB regulon is 
known to respond to different stress signals and accordingly regulates stress  responses33. One of the marker genes 
upregulated by SigB is asp2337. An increase of SigB activity in P3.1 was suspected by noteworthy pigmentation of 
P3.1 colonies. Indeed, another known SigB-regulated trait is production of  staphyloxanthin38. Further assessment 
revealed that P3.1 produced pigments whereas the parental strain HU-14 did not, as determined spectrophoto-
metrically. In the present report, the significant increase in asp23 expression revealed that the increase in SigB 
functionality was associated with the recovery of CP5 production. It is hypothesized that adaptation of S. aureus 
through a long-term process in the host may have led to reduced SigB expression and perhaps loss of the Agr 
function seen in HU-14. Experimental passage of this isolate through the bloodstream induced reacquisition of 
CP expression with parallel increase of SigB expression, as ascertained by increased asp23 expression. In favor of 
this hypothesis, Marbach and  coworkers39 has found that S. aureus infecting the bovine udder may not require 
sigB expression once it is established in the mammary gland of the cow with chronic mastitis. Interestingly, as 
we hypothesized before, loss of SigB expression in the infected cow was eventually fixed by  mutation8. In this 
case the mutated gene was rsbU39.
Whole genome sequence analysis from reads obtained by Illumina sequencing did not reveal any genetic 
lesion directly or indirectly responsible for the observed SigB increased expression. Therefore, the presence of 
structural changes in P3.1 was then investigated by long-read sequencing. Hybrid (PacBio and Illumina) sequence 
analysis of the HU-14 and P3.1 chromosomes as well as of plasmid pCM05 suggested a structural change in 
Figure 6.  (a,b) RAW 264.7 cells were stimulated with the S. aureus HU-14 isolate or its derivative P3.1 
(Heat-killed bacteria,  107 CFU/ml) for 48 h. Media alone was used as negative control. (a) Photographs at 
20 × magnification. (b) The number of mature osteoclasts was quantified by light microscopy using TRAP 
staining. TRAP + cells with 3 or more nuclei were considered mature osteoclasts. The mean and standard error 
of cumulative data from 3 independent experiments (6 wells) is shown. Levels of significance were obtained by 
ordinary one-way ANOVA (Tukey´s multi comparisons test, Brown-Forsythe post-test). (c) TNF-α production 
was quantified by ELISA in the culture media. The mean and standard error of cumulative data from 3 
independent experiments (6 wells) is shown. Levels of significance were obtained by ordinary one-way ANOVA 
(Tukey’s multi comparisons test, Brown-Forsythe post-test).
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P3.1 compared with HU-14, which consisted of an IS256 excision located between dnaG (DNA primase) and 
rpoD (sigA). This preliminary observation was not surprising since mobile genetic elements are key drivers of 
evolution in S. aureus40. Giulieri and  coworkers41 have indeed demonstrated that insertion of IS256 elements 
enhances genetic diversity during infection thus representing an effective driver of within-host microevolution. 
Furthermore, insertion of IS256 in agrC was found to promote increased fitness of S. aureus as a compensatory 
mechanism for the biological cost resulting from acquisition of a high number of multiresistant traits by hospital 
 isolates42. In this regard, it is speculated that reacquisition of SigB activity and CP5 as well as staphyloxanthin 
production was perhaps achieved by restoration of SigA activity since IS256 was excised without affecting the 
original conserved intergenic non-coding region between dnaG (DNA primase) and rpoD (sigA). In support of 
this hypothesis, it has been shown that the sigB operon is transcribed from at least two differentially controlled 
promoters, one of which is a putative σA-dependent promoter termed sigBP143. Therefore, sigB expression is 
driven by SigA, which leads to the transcription of the whole operon, as well as through autoregulation by SigB 
itself, leading to transcription of rsbV and rsbW33. Further research is required to better understand the complex 
mechanisms that permit concomitant reacquisition of CP5 and pigment production by S. aureus in the presence 
of an inactive agr and a functional sigB operon, which is known to be driven by SigA.
Altman and coworkers have shown that within-host loss of agr function was associated with increased genetic 
divergence between distinct S. aureus  subclones44. In synthesis, whereas agr dysfunction is adaptive for survival in 
the infected bone, it may be counter adaptive outside such niche. As observed before, agr mutations do not tend 
persist in natural S. aureus  populations45. In the present report we show that S. aureus can regain CP production 
when subjected to selection pressure in vivo through a mechanism that does not require RNAIII expression. 
Indeed, in a previous study it has been shown that genetic changes occurring in an agr-defective infecting S. 
aureus strain resulted in increased virulence in a murine model of bloodstream infection thus bypassing the agr 
 mutation44. The S. aureus derivative obtained after passage through the bloodstream displayed a significant reduc-
tion in the capacity to trigger TNFα production and became less adapted to bone as ascertained by its decreased 
capacity to induce osteoclastogenesis. The S. aureus strain adapted to blood not only conserved but increased its 
capacity to produce biofilm. Recovery of at least two important traits such as CP5 and pigment production permit 
bacteria to evade innate immune mechanisms of defense in the  blood46–49 and readapt to a new environment 
elsewhere in the host with the potential to cause methastatic infection. The fact that S. aureus can adapt to blood 
by regaining the capacity to produce CP5 and pigments does not necessarily mean that virulence should increase. 
P3.1 exhibited a trend to be more virulent, as ascertained in the mouse model of intraperitoneal challenge, but 
the differences were not significant. This was not a surprising fact since the Agr remained non-functional and 
many other Agr-regulated virulence factors are not being expressed, such as the hemolysins. Therefore, as much 
as S. aureus is a multifactorial pathogen, it is speculated that its adaptation to a given niche in the host is most 
probably multifactorial too. In the present study, modification of virulence factor expression due to increased 
SigB activity was enough to reduce adaptation to bone but not to increase virulence in a significant fashion.
conclusion
Here we demonstrated that S. aureus adapted to infected bone can regain the ability to produce CP, even in 
the presence of a mutated, non-functional Agr when transferred to the bloodstream. S. aureus organisms that 
escape the infected bone can potentially become a threat because they can recover in a stable manner the expres-
sion of traits that permit survival in blood, such as CP and staphyloxanthin. Therefore, a supposedly harmless 
endpoint-of-microevolution may turn back into a dangerous infective derivative. Given that CP is one of the 
factors identified in this microevolution process, our findings support the idea that S. aureus CP should not be 
dismissed as a multifactorial vaccine candidate component.
Materials and methods
Bacterial strains and cultures. Staphylococcus aureus clinical isolate HU-14 from our strain collection 
was originally recovered in 2005 from a 34-year old male patient with chronic osteomyelitis of the right femur 
with a prosthetic implant (“Hospital Ramón Carrillo”, Buenos Aires, Argentina). Species was confirmed by a 
species-specific  PCR50. Strain HU-14 is ST5, CC5, SCCmec type 1, Agr type II and Spa  t14951. All strains utilized 
in the study were kept frozen in trypticase soy broth (TSB) with 20% glycerol at − 80 °C and S. aureus was rou-
tinely cultured at 37 °C for 24 h on TSB unless otherwise indicated. In addition, S. aureus strain 6850 was used 
as a qRT-PCR positive control for Agr and SigB functionality testing. S. aureus strains RN6911 and SH1000 were 
utilized as negative and positive controls, respectively, for staphyloxanthin production. S. aureus strains Sa113 
and MBD034 were utilized as positive and negative controls, respectively, for PIA production. Strain HU-8 
(CC5, SCCmec type 1, Agr type II, Spa t149 and produces CP5), which bears a functional agrC, was also utilized 
as control.
Mouse models. CF1 outbred mice were bred and maintained in the vivarium of the “Instituto de Investi-
gaciones en Microbiología y Parasitología Médica” (IMPaM-Universidad de Buenos Aires-CONICET, Buenos 
Aires, Argentina). Animal care was in accordance with the recommendations of the guidelines set forth by 
the 11th report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on  Refinement52. The animal 
research protocols utilized in this study were approved by the “Comité Institucional para el Uso y Cuidado de 
los Animales de Laboratorio,” through resolutions No. 885/19 issued on June 5, 2019 and  No 2780/18 issued on 
February 5, 2019 by the “Consejo Directivo de la Facultad de Medicina, Universidad de Buenos Aires,” Argen-
tina. The experimental scheme of the mouse bacteriemia model is shown in Fig. 1. Passage of S. aureus strain 
HU-14 through blood was performed on groups of 4 male mice in each cycle. An inoculum of 1 × 108 CFU in 
100 µl of physiologic saline solution (PSS) was injected in mice by the ip route. After 24 h mice were sacrificed 
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by exposure to  CO2 and blood was drawn by cardiac puncture and quantitatively plated on trypticase soy agar 
(TSA). Plates were incubated for 24 h at 37 °C and colonies were suspended PSS to ca. 1 × 109 CFU to prepare 
a  108 CFU inoculum to be re-injected in the next group of mice. This cycle was repeated seven times. To assess 
the differential virulence of the strains under investigation mortality curves were compared. Groups of 10 CF1 
outbred mice were injected with 1 × 108 CFU of the strain to be tested suspended in 0.5 ml of 2% (w/v) Brewer´s 
yeast (Sigma Chemical Co.) in TSB broth. Mortality and body weight were assessed daily for 5 days. Surviving 
mice were euthanized by cervical dislocation. The Kaplan–Meier mortality curve was obtained using the Graph-
Pad Prism software (GraphPad Software, Inc., La Jolla, USA; version 6.00).
illumina whole genome sequencing and analysis. DNA was extracted directly from plated microbial 
cultures using the Nextera DNA Flex Microbial Colony Extraction protocol (Illumina, San Diego, CA, USA). 
Library preparation was performed according to the Nextera DNA Flex Library Prep Kit using Nextera DNA 24 
CD Indexes (Illumina, San Diego, CA, USA). Paired-end whole genome sequencing was performed in a MiSeq 
instrument (Illumina, San Diego, CA, USA) using the MiSeq Reagent kit v2 150 bp. The resulting fastq files were 
analyzed with the FastQC High Throughput Sequence QC Report Version 0.11.7 (https ://www.bioin forma tics.
babra ham.ac.uk/proje cts/). Only isolates that fulfilled the quality parameters of the FastQC software (e.g. per 
base sequence quality, per tile sequence quality, per sequence GC content) were used for analysis. The FastQ files 
were assembled using SPAdes v3.10.153. The genome was annotated using Prokka v1.14.554 and variant calling 
was performed using Snippy v3.2 (https ://githu b.com/tseem ann/snipp y). The sequences analyzed in this study 
have been deposited in the European Nucleotide Archive (ENA) under Bioproject PRJEB35732.
Pacific biosciences genome sequencing and analysis.  High molecular weight (HMW) gDNA was 
extracted from HU-14 and P3.1. Bacteria were grown overnight on TSA plates, then gDNA was extracted using 
Qiagen’s MagAttract HMW DNA Kit (Qiagen, Manchester, UK) according to the manufacturer’s instructions for 
Gram Positive species, using 20 µl of lysostaphin (10 mg/ml) instead of lysozyme. The extracted HMW gDNA 
was sent to the Centre for Genomic Research at the University of Liverpool, UK, where long-read sequencing 
and base modification analysis were conducted on the Pacific Biosciences (Pacific Biosciences, Menlo Park, CA, 
USA) Sequel system. The raw subreads for each sample were filtered to 200 × coverage of the S. aureus genome 
using Filtlong v0.2.0 (available at https ://githu b.com/rrwic k/Filtl ong) and then corrected using Canu v1.955. 
Hybrid de novo assemblies were produced for both samples by Unicycler v0.4.856, using the PacBio long reads 
and Illumina short reads. In hybrid mode, Unicycler uses SPAdes v3.14.053 to assemble the short reads, then 
bridges the SPAdes contigs and closes the genome using the long reads with minimap and miniasm (built-in 
Unicycler v0.4.8 versions)57, followed by long-read polishing with Racon v1.4.1158 and short-read polishing with 
Pilon v1.2259. The completeness of the closed genome sequences was assessed using BUSCO v4.0.260. The “bacte-
ria” database was used to search the genomes for 120 universal bacterial genes, and the more specific “Bacillales” 
database was used to search for 450 genes common to all Bacillales species. Prokka v1.14.554 was used to anno-
tate the closed genome sequences, using the protein sequences from the S. aureus strain N315 (NC_00275.2) as a 
reference. The annotated GenBank format files were then used to call SNPs between the two samples with Snippy 
v4.5.1 (https ://githu b.com/tseem ann/snipp y); the HU-14 GenBank file was used as the reference with the P3.1 
Illumina reads, and vice-versa. The plasmid sequence for each sample was compared to the PLSDB plasmid data-
base v.2019_10_0761 (11), and annotated with Prokka (1.14.5)54 to confirm its identity. The closed chromosome 
and plasmid sequences from each sample were rotated to start with the same genes (dnaA for the chromosome, 
repA for the plasmid) and aligned using progressiveMauve (build version: Sep 16 2015). The output files were 
inspected visually for any rearrangements using the progressiveMauve GUI.
phenotypic studies. CP5 production was evaluated by colony immunoblot on TSA plates as described 
 previously62. Phenotypic expression of α- and β-hemolysin was performed by evaluating the production of the 
hemolysis in rabbit and goat blood agar (α- and β-hemolysin, respectively). Proteolytic activity was assessed in 
TSA supplemented with 10% whole milk. After 18 h incubation at 37 °C the hemolytic and proteolytic halos 
were evaluated, respectively. Ethanolic extracts of the carotenoid pigment from bacterial suspensions with equal 
optical density (OD) at 600 nm were quantified spectrophotometrically at 450 nm63. The quantitative assessment 
of biofilm formation was performed as previously described with  modifications64. Briefly, S. aureus strains were 
grown for 18 h and diluted 1:100 in TSB supplemented with 0.25% of glucose (TSBg). After 24 h of static incuba-
tion at 37 °C in 96-well microtiter plates, bacterial growth in each well was measured by optical density reading 
at 595 nm  (ODG) using a microplate reader (Multiskan EX). Then, the wells were washed two times with PBS, 
the biofilms were fixed with 100% methanol for 15 min, stained with 0.5% crystal violet for 20 min, and washed 
twice again gently under running tap water. The amount of biofilm biomass was measured after addition of 30% 
glacial acetic acid by OD reading at 595 nm  (ODB). The biofilm biomass was expressed relative to the final cell 
density measured prior to crystal violet staining (biofilm  ODB/ODG). Three independent experiments were per-
formed in sixtuplicate measurements. PIA production was assessed by ELISA according to a protocol described 
 elsewhere64. Briefly, the procedure was similar to that described above for biofilm except that, after blocking 
solution removal,100 μl per well was added of a 75 ng/ml wheat germ agglutinin (WGA)-HRP conjugate, a lectin 
that binds to PIA sugar residues.
Real-time quantitative reverse transcription PCR (qRT-PCR).  Bacterial RNA was extracted from S. 
aureus grown in TSB until post-exponential phase, using TRIzol Reagent (Invitrogen Life Technologies), accord-
ing to the manufacturer’s protocol. RNA was subjected to DNAse treatment using a RQ1 RNAse free DNAse 
(Promega). cDNA synthesis was performed with an ImProm-II Reverse Transcriptase kit (Promega). qRT-PCR 
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for RNAIII, agrA and asp23 expression were performed using the primers and conditions described in a previ-
ous  publication9 and the SYBR Green PCR Master Mix (Applied Biosystems) equipment and kits. The 16S gene 
was used to normalize data. The (− ΔCt) value represents the difference in threshold cycle (Ct) between the target 
and control(16S)  genes65.
Osteoclastogenesis  assay  and TNFα  detection.  To determine the differential capacity of strains 
HU-14 and P3.1 to trigger osteoclastogenesis RAW 264.7 cells were plated on coverslips (2,5 × 104 cells/well, 
24 well plate) in the presence of M-CSF 30 ng/ml (MACS Miltenyi Biotec) and 107 CFU/ml or each S. aureus 
strain or media alone. At 48 h after stimulation cells were fixed in 4% paraformaldehyde and stained for Tartrate-
Resistant Acid Phosphatase (TRAP) (Sigma-Aldrich, St. Louis, MO, USA). Multinucleated (more than three 
nuclei), TRAP-positive cells were defined as osteoclasts and  counted66. TNFα concentrations were determined 
quantitatively in culture supernatants collected at 24 h after stimulation by ELISA using specific antibody pairs 
(Beckton-Dickinson) as described  previously67.
Statistical considerations. Multiple data statistical comparison was performed by ordinary one-way 
ANOVA using the Tukey´s multi comparisons test and the Bartlett-Forsythe post-test. Statistical comparison of 
two data groups with normal distribution was performed with the Student t test for unpaired samples. Statisti-
cal comparison of two data groups with non-normal distribution was performed with the Mann–Whitney test. 
P < 0.05 was considered statistically significant. Graph-Pad Prism software (GraphPad Software, Inc., La Jolla, 
USA; version 6.00) was used for all statistical analyses.
Data availability
The sequences analyzed in this report have been deposited in the European Nucleotide Archive (ENA) under 
Bioproject PRJEB35732. Other datasets generated and/or analyzed during the current study are available from 
the corresponding author upon request.
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